InvestorsHub Logo
Followers 1
Posts 18
Boards Moderated 0
Alias Born 10/18/2017

Re: QuidWilson post# 61466

Wednesday, 11/01/2017 3:36:51 PM

Wednesday, November 01, 2017 3:36:51 PM

Post# of 140474
Anyone who invested in TRXC should have sold after FDA approval. It's all downhill as the market will never support that system. It's a joke as compared to Titan or even the very first Davinci S system. Maybe if it debuted in the 1990s after straight laparoscopy surgery was taking off, it would have been a substantive advance. In 2017 it offers nothing to the robotic market. Even more crazy is their system cost more than the fully loaded DaVinci Xi. And haptic feedback... If one can't perform robotic surgery with 3D vision, magnification, and precise movements alone, he/she probably shouldn't be performing robotic surgery.

I have a robot prostatectomy tomorrow. The Xi does it fairly well. I haven't used Sport but every video I've seen looks as if it can do it better. Of course I recognize watching a video vs using the system is not the same thing. A final point, the Michael Jordan of robotic prostatectomy, Vip Patel, doesn't touch this system with a 10 foot pole if isn't a viable technology.